Condition

NAFLD (Non-alcoholic Fatty Liver Disease) clinical trials and research

• 7Clinical trials
• 4Countries

Newest NAFLD (Non-alcoholic Fatty Liver Disease) clinical trials

All recruiting trials (7)

• HP515 for non-alcoholic fatty liver disease (NASH/MASH)

  This trial tests whether daily HP515 tablets can reduce liver fat and are safe in adults (18–65) with non-alcoholic fatty liver disease and liver fat ≥10%.

  Recruiting Phase 2 Hinova Pharmaceuticals Inc. · Beijing, Beijing Municipality and 1 other locations · NCT07308548

• Ultrasound method to measure liver fat percentage

  This study will test whether a new ultrasound technique can accurately measure the percentage of fat in the liver for adults with or at risk for MASLD (formerly NAFLD) and for healthy volunteers.

  Recruiting ContextVision AB · Seattle, Washington · NCT07270601

• Community-based study of fatty liver in older adults

  This study tests how common fatty liver disease is among people 65 and older and looks at lifestyle, environment, and genetics to see what factors influence it.

  Recruiting The Affiliated Hospital of Hangzhou Normal University · Hangzhou, Zhejiang · NCT07241195

• Multiple under-the-skin injections of B1344 for adults with NAFLD and NASH

  This trial will test whether repeated subcutaneous injections of an experimental drug called B1344 are safe and affect liver fat and related measures in adults with NAFLD or NASH.

  Recruiting Phase 1 Tasly Biopharmaceuticals Co., Ltd. · Beijing, Beijing Municipality and 4 other locations · NCT07128797

• Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD

  This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.

  Recruiting at 3 sites University of Nottingham · Nottingham, United Kingdom and 2 other locations · NCT07093346

• Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD

  This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.

  Recruiting at 3 sites University of Nottingham · Nottingham, United Kingdom and 2 other locations · NCT07093346

• Telehealth program for weight management and related health issues

  This study is testing a new telehealth program for weight management to see if it helps obese adults with type 2 diabetes and liver issues lose weight and improve their health better than traditional in-person programs.

  Recruiting Changi General Hospital · Singapore · NCT06890169

Related topics

Quick answers

How many NAFLD (Non-alcoholic Fatty Liver Disease) clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (3 trials), United Kingdom (2 trials), Singapore (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →